P3 Health Partners Inc. (PIII)
NASDAQ: PIII · Real-Time Price · USD
0.440
+0.012 (2.90%)
At close: Oct 22, 2024, 4:00 PM
0.441
+0.001 (0.14%)
Pre-market: Oct 23, 2024, 7:03 AM EDT

Company Description

P3 Health Partners Inc., a patient-centered and physician-led population health management company, provides superior care services in the United States.

It operates clinics and wellness centers. P3 Health Partners Inc. was founded in 2020 and is based in Henderson, Nevada.

P3 Health Partners Inc.
P3 Health Partners logo
Country United States
Founded 2015
Industry Medical Care Facilities
Sector Healthcare
Employees 400
CEO Aric Coffman

Contact Details

Address:
2370 Corporate Circle, Suite 300
Henderson, Nevada 89074
United States
Phone 702 910 3950
Website p3hp.org

Stock Details

Ticker Symbol PIII
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001832511
CUSIP Number 744413105
ISIN Number US7444131053
Employer ID 85-2992794
SIC Code 8000

Key Executives

Name Position
Dr. Aric Coffman M.D. Chief Executive Officer and President
Dr. Sherif Abdou F.A.C.E.P., FACP, M.D. Co-Founder, Vice Chairperson of the Board and Strategic Advisor
Dr. Amir Bacchus M.B.A., M.D. Co-Founder, Chief Medical Officer and Director
Leif Pedersen Chief Financial Officer
William Bettermann Executive Vice President and Chief Operating Officer
Devery Goodey Senior Vice President of Technology
Sarah Bussmann B.S.N., CRNI, M.H.A., R.N. Chief Administrative Officer
Roy Youngblood Senior Director of Compliance
Leslie P. Fisher Senior Vice President of Legal Affairs, General Counsel and Corporate Secretary
Kassi Belz APR Executive Vice President of Communications, Culture and Engagement

Latest SEC Filings

Date Type Title
Aug 29, 2024 8-K Current Report
Aug 7, 2024 10-Q Quarterly Report
Aug 7, 2024 8-K Current Report
Jun 28, 2024 424B3 Prospectus
Jun 27, 2024 EFFECT Notice of Effectiveness
Jun 26, 2024 SC 13D/A [Amend] General statement of acquisition of beneficial ownership
Jun 24, 2024 UPLOAD Filing
Jun 18, 2024 S-3 Registration statement under Securities Act of 1933
Jun 7, 2024 8-K Current Report
May 24, 2024 8-K Current Report